Mutations in genes such as SNCA, LRRK2, PINK1, and Parkin significantly increase the risk of PD among carriers, and these genetic mutations are often closely linked to damage to mitochondrial function and subsequent degradation of damaged mitochondria.15 This evidence concerns the gene LRRK2 and Parkinson disease.